Detalhe da pesquisa
1.
Sars-CoV2 infection in pregnant women with multiple sclerosis.
Mult Scler;
29(9): 1090-1098, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37232279
2.
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Neurol Sci;
44(11): 4001-4011, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37311951
3.
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line.
Curr Issues Mol Biol;
44(3): 1247-1256, 2022 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35723306
4.
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
J Neuroinflammation;
19(1): 19, 2022 Jan 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35057809
5.
NURR1-deficient mice have age- and sex-specific behavioral phenotypes.
J Neurosci Res;
100(9): 1747-1754, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35593070
6.
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Ann Neurol;
89(4): 780-789, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33480077
7.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
J Neurol Neurosurg Psychiatry;
2022 Sep 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36180219
8.
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Mult Scler;
28(7): 1034-1040, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34328824
9.
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.
Eur J Neurol;
29(2): 535-542, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34735749
10.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Eur J Neurol;
29(12): 3728-3736, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36086905
11.
A real-world study of alemtuzumab in a cohort of Italian patients.
Eur J Neurol;
29(1): 257-266, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34558755
12.
The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes.
Mol Biol Rep;
49(6): 4709-4718, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35279776
13.
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
Mult Scler;
27(3): 331-346, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32940121
14.
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Mult Scler;
27(3): 347-359, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32940128
15.
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report.
Neurol Sci;
42(Suppl 1): 25-28, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33712907
16.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Mult Scler;
26(12): 1519-1531, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31573386
17.
Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis.
Dermatol Ther;
33(6): e13943, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32614114
18.
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study.
Neurol Sci;
41(10): 2843-2851, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32318950
19.
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.
Mult Scler;
25(3): 399-407, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29363396
20.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
J Neuroinflammation;
13(1): 279, 2016 09 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27788675